In total, these observations suggest that aberrant increase of HSP90 in CLL cells may potentiate the BCR signal likely by chaperoning multiple critical components of the BCR pathway including CD79a, BCAP, PLCγ2, LYN, SYK, BTK and AKT from proteosomal degradation. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.